ACER - Acer Therapeutics EPS beats by $0.30 beats on revenue May, 17 2021 04:28 PM Acer Therapeutics Inc. Acer Therapeutics (ACER): Q1 GAAP EPS of -$0.11 beats by $0.30.Revenue of $3.99M beats by $3.49M.Press Release For further details see: Acer Therapeutics EPS beats by $0.30, beats on revenue